Germacrone exerts anti-cancer effects on gastric cancer through induction of cell cycle arrest and promotion of apoptosis

BMC Complement Med Ther. 2020 Jan 23;20(1):21. doi: 10.1186/s12906-019-2810-3.

Abstract

Background: Germacrone is one of the natural bioactive compounds found in Rhizoma curcuma essential oils. In this study, the potential anti-cancer effect of germacrone in gastric cancer cell line BGC823 was investigated.

Methods: The cell viability and proliferative activity were assessed, and cell cycle analysis was also performed. Hoechst 33258 and Annexin V/PI double staining was used for detection of cell apoptosis. Protein profiles of cell cycle-related and apoptosis-related proteins were assessed.

Results: MTT assay revealed that germacrone had marked cytotoxicity on BGC823 cells. Germacrone induced cell cycle arrest in the G2/M phase via remarkably decreased expression levels of cyclin B1, cdc 2 and cdc 25c. In addition, the treatment with germacrone induced caspase-3 activity and PARP cleavage. These findings demonstrated the effects of germacrone on inhibiting cell proliferation through induction of G2/M phase cell cycle arrest and promotion of cell apoptosis. It also indicated that germacrone functioned through modulations of cell cycle-associated protein expression and mitochondria-mediated apoptosis.

Conclusion: These findings will be valuable as the molecular basis for the germacrone-mediated anti-cancer effect against gastric cancer.

Keywords: Apoptosis; BGC823 cells; Cell cycle arrest; Gastric cancer; Germacrone.

MeSH terms

  • Apoptosis / drug effects*
  • Blotting, Western
  • Cell Cycle Checkpoints / drug effects*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects*
  • Flow Cytometry
  • Humans
  • Oils, Volatile / pharmacology*
  • Sesquiterpenes, Germacrane / pharmacology*
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / pathology*

Substances

  • Oils, Volatile
  • Sesquiterpenes, Germacrane
  • germacrone